跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection - SFDA Drug Approval Details
Approvals
/
SFDA
/
DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection
Authorized
NCE
DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
37c943a2899d964f
Company
Unknown
Type
NCE
Approval Details
Approval Id
37c943a2899d964f
Drug Approval Sfda Name
DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection
Trade Name
DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection
Generic Name
TRIPTORELIN
Register Number
0112222955
Register Year
2017
Drug Type
NCE
Route Of Administration
Intramuscular use
Package Type
Vial
Package Size
1
Size
2
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Restricted
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000001283-11.25-200000016487
Price
1204
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
37c943a2899d964f
Type
NCE
Back to SFDA Approvals